Related Articles
Effects of addition of rituximab to chemotherapy on central nervous system events in patients with diffuse large B‑cell lymphoma
BR vs. R‑miniCHOP in unfit patients with B‑cell non‑Hodgkin lymphoma: A randomized, two‑center, cohort study
Central nervous system involvement in adult patients with diffuse large B-cell lymphoma: Influence of rituximab
Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study
Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: A single center experience